Letter | Published:

Macrophage-specific PPARγ controls alternative activation and improves insulin resistance

Nature volume 447, pages 11161120 (28 June 2007) | Download Citation

Abstract

Obesity and insulin resistance, the cardinal features of metabolic syndrome, are closely associated with a state of low-grade inflammation1,2. In adipose tissue chronic overnutrition leads to macrophage infiltration, resulting in local inflammation that potentiates insulin resistance3,4. For instance, transgenic expression of Mcp1 (also known as chemokine ligand 2, Ccl2) in adipose tissue increases macrophage infiltration, inflammation and insulin resistance5,6. Conversely, disruption of Mcp1 or its receptor Ccr2 impairs migration of macrophages into adipose tissue, thereby lowering adipose tissue inflammation and improving insulin sensitivity5,7. These findings together suggest a correlation between macrophage content in adipose tissue and insulin resistance. However, resident macrophages in tissues display tremendous heterogeneity in their activities and functions, primarily reflecting their local metabolic and immune microenvironment8. While Mcp1 directs recruitment of pro-inflammatory classically activated macrophages to sites of tissue damage5,8, resident macrophages, such as those present in the adipose tissue of lean mice, display the alternatively activated phenotype9. Despite their higher capacity to repair tissue10, the precise role of alternatively activated macrophages in obesity-induced insulin resistance remains unknown. Using mice with macrophage-specific deletion of the peroxisome proliferator activated receptor-γ (PPARγ), we show here that PPARγ is required for maturation of alternatively activated macrophages. Disruption of PPARγ in myeloid cells impairs alternative macrophage activation, and predisposes these animals to development of diet-induced obesity, insulin resistance, and glucose intolerance. Furthermore, gene expression profiling revealed that downregulation of oxidative phosphorylation gene expression in skeletal muscle and liver leads to decreased insulin sensitivity in these tissues. Together, our findings suggest that resident alternatively activated macrophages have a beneficial role in regulating nutrient homeostasis and suggest that macrophage polarization towards the alternative state might be a useful strategy for treating type 2 diabetes.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    , & Inflammation and insulin resistance. J. Clin. Invest. 116, 1793–1801 (2006)

  2. 2.

    Inflammation and metabolic disorders. Nature 444, 860–867 (2006)

  3. 3.

    et al. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112, 1796–1808 (2003)

  4. 4.

    et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112, 1821–1830 (2003)

  5. 5.

    et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J. Clin. Invest. 116, 1494–1505 (2006)

  6. 6.

    et al. Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J. Biol. Chem. 281, 26602–26614 (2006)

  7. 7.

    et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J. Clin. Invest. 116, 115–124 (2005)

  8. 8.

    & Monocyte and macrophage heterogeneity. Nature Rev. Immunol. 5, 953–964 (2005)

  9. 9.

    , & Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117, 175–184 (2007)

  10. 10.

    Alternative activation of macrophages. Nature Rev. Immunol. 3, 23–35 (2003)

  11. 11.

    & The many faces of PPARγ. Cell 123, 993–999 (2005)

  12. 12.

    et al. Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase. Nature 400, 378–382 (1999)

  13. 13.

    et al. Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation. Cell Metab. 4, 13–24 (2006)

  14. 14.

    et al. Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity 20, 623–635 (2004)

  15. 15.

    et al. Enhancer-mediated control of macrophage-specific arginase I expression. J. Immunol. 172, 7565–7573 (2004)

  16. 16.

    , & PPARs and the complex journey to obesity. Nature Med. 10, 355–361 (2004)

  17. 17.

    , & Leishmania species: models of intracellular parasitism. J. Cell Sci. 112, 2993–3002 (1999)

  18. 18.

    , , , & Impairment of alternative macrophage activation delays cutaneous leishmaniasis in nonhealing BALB/c mice. J. Immunol. 176, 1115–1121 (2006)

  19. 19.

    & Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444, 847–853 (2006)

  20. 20.

    et al. Cutting edge: Stat6-dependent substrate depletion regulates nitric oxide production. J. Immunol. 166, 2173–2177 (2001)

  21. 21.

    et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nature Genet. 34, 267–273 (2003)

  22. 22.

    et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc. Natl Acad. Sci. USA 100, 8466–8471 (2003)

  23. 23.

    et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300, 1140–1142 (2003)

  24. 24.

    et al. Hypomorphic mutation of PGC-1β causes mitochondrial dysfunction and liver insulin resistance. Cell Metab. 4, 453–464 (2006)

  25. 25.

    & Transcriptional regulatory circuits controlling mitochondrial biogenesis and function. Genes Dev. 18, 357–368 (2004)

  26. 26.

    , & Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab. 1, 361–370 (2005)

  27. 27.

    How obesity causes diabetes: not a tall tale. Science 307, 373–375 (2005)

  28. 28.

    et al. Role of adiponectin in human skeletal muscle bioenergetics. Cell Metab. 4, 75–87 (2006)

  29. 29.

    et al. Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux. Mol. Cell. Biol. 22, 2607–2619 (2002)

  30. 30.

    , & Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins. Am. J. Physiol. Endocrinol. Metab. 292, E166–E174 (2007)

Download references

Acknowledgements

We thank members of the Chawla laboratory for comments, and A. Loh and C. H. Lee for critiquing the manuscript. We also thank P. Murray, J. McKerrow and O. McGuinness for providing key reagents and technical guidance. This work was supported by grants made available to A.C. from the NIH, the Astellas Foundation, Takeda Pharmaceuticals North America, the Rockefeller Brothers Fund and by Goldman Philanthropic Partnerships; and to A.W.F. from the NIH and Columbia DERC. A.C. is a Charles E. Culpeper Medical Scholar. Support was provided by Stanford MSTP (to J.I.O. and A.R.E.), the AHA (to J.I.O.), a HHMI Gilliam fellowship (to A.R.E.), the NRSA (to R.R.R.-G.), and an NIH Training Grant (to L.M.). All animal care was in accordance with Stanford University’s A-PLAC committee guidelines.

Author Contributions J.I.O and R.R.R.-G were involved in project planning, experimental work and data analysis; M.H.G, C.R.M, V.S, L.M., D.V. and A.R.E. performed experimental work; F.B. was involved in project planning; and A.W.F. and A.C. were involved in project planning, data analysis and manuscript preparation.

Author information

Author notes

    • Justin I. Odegaard
    •  & Roberto R. Ricardo-Gonzalez

    These authors contributed equally to this work.

Affiliations

  1. Division of Endocrinology, Metabolism and Gerontology, Department of Medicine

    • Justin I. Odegaard
    • , Roberto R. Ricardo-Gonzalez
    • , Matthew H. Goforth
    • , Christine R. Morel
    • , Lata Mukundan
    • , Alex Red Eagle
    • , Divya Vats
    •  & Ajay Chawla
  2. Graduate Program in Immunology,

    • Justin I. Odegaard
    • , Roberto R. Ricardo-Gonzalez
    •  & Ajay Chawla
  3. Department of Genetics, Stanford University School of Medicine, Stanford, California 94305-5103, USA

    • Alex Red Eagle
  4. Department of Medicine, Naomi Berrie Diabetes Center, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA

    • Vidya Subramanian
    •  & Anthony W. Ferrante
  5. Institute of Infectious Disease and Molecular Medicine, Division of Immunology, Health Science Faculty, University of Cape Town, Werhner Beit South, Observatory, 7925, Anzioroad, Cape Town, South Africa

    • Frank Brombacher

Authors

  1. Search for Justin I. Odegaard in:

  2. Search for Roberto R. Ricardo-Gonzalez in:

  3. Search for Matthew H. Goforth in:

  4. Search for Christine R. Morel in:

  5. Search for Vidya Subramanian in:

  6. Search for Lata Mukundan in:

  7. Search for Alex Red Eagle in:

  8. Search for Divya Vats in:

  9. Search for Frank Brombacher in:

  10. Search for Anthony W. Ferrante in:

  11. Search for Ajay Chawla in:

Competing interests

Reprints and permissions information is available at www.nature.com/reprints. The authors declare no competing financial interests.

Corresponding author

Correspondence to Ajay Chawla.

Supplementary information

PDF files

  1. 1.

    Supplementary Information 1

    This file contains Supplementary Figures S1-S6 with Legends and Supplementary Table S1.

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/nature05894

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.